Urofollitropin

Generic Name
Urofollitropin
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
97048-13-0
Unique Ingredient Identifier
W9BB98U6HP
Background

Urofollitropin is a urinary-derived follicle-stimulating hormone (FSH) that is extracted and purified from human urine samples. It consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glycosylated at Asn 7 and Asn 24. Urofollitropin is typically used injected subcutaneously in combination with human chorionic gonadotropin (hCG) to induce ovulation. Urofollitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).

Indication

For treatment of female infertility

Associated Conditions
-
Associated Therapies
Assisted Reproductive Technology therapy, Ovulation induction therapy

FSH Treatment for Non-obstructive Azoospermic Patients

Phase 3
Conditions
Interventions
First Posted Date
2014-10-27
Last Posted Date
2015-02-02
Lead Sponsor
Azienda Sanitaria Locale Bari
Target Recruit Count
200
Registration Number
NCT02275169

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-10-25
Last Posted Date
2019-10-09
Lead Sponsor
IBSA Institut Biochimique SA
Target Recruit Count
710
Registration Number
NCT01969201
Locations
🇨🇭

Universitätsklinik für Frauenheilkunde, Bern, Be, Switzerland

🇮🇹

IRCCS San Raffaele, Milan, Italy

🇧🇪

Universitair Ziekenhuis Brussel, Brussels, Belgium

and more 13 locations
© Copyright 2024. All Rights Reserved by MedPath